Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $105.3900 (-1.7%) ($105.3900 - $105.3900) on Wed. Aug. 18, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.18% (three month average) | RSI | 15 | Latest Price | $105.3900(-1.7%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.8% a day on average for past five trading days. | Weekly Trend | LGND declines -2.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) IWM(56%) IWC(54%) IWN(51%) | Factors Impacting LGND price | LGND will decline at least -1.09% in a week (0% probabilities). VIXM(-27%) VXX(-17%) UUP(-17%) UNG(-4%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.09% (StdDev 2.18%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $99.38(-5.7%) | Resistance Level | $112.55 | 5 Day Moving Average | $107.1(-1.6%) | 10 Day Moving Average | $108.3(-2.69%) | 20 Day Moving Average | $112.55(-6.36%) | To recent high | -23.3% | To recent low | 0% | Market Cap | $1.694b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |